Akcie - Fundamenty - Všechna data pro vaši analýzu

Nástroje

Akciový screener

Kalendář zisků

Super investoři

Ostatní

Návod

IČ: 19940963

5. května 521, 501 01 Turnov

Zásady GDPR

Podmínky služby

Všechna práva vyhrazena @ 2024, Fundamenty.cz

Proudly created by draftspot.net

Elevance Health Inc.

ELV

Valuace

Růst

Zdraví

Cena

$ 305.00

--7.06 (-1.85%)

Souhrn

Výkazy

Ukazatele

Profil

Držitelé

Návštěvnost webu

Konkurence

Zprávy společnosti

Kapitalizace

67.8B

Obrat

199B

Zisk

Aktiva

123B

Dluh

ROE

ROA

Cena 1R

274-459

⌀ Cena

350.58

Dividenda

0.0(0.0%)

Čtvrtletní 10-Q

Celoroční 10-K

Nadcházející oznámení zisků

22-04-2026

Poslední dividenda

10-03-2026

Profil

Elevance Health Inc. působí jako společnost poskytující zdravotní dávky. Podporuje spotřebitele, rodiny a komunity napříč celou pečovatelskou trasou, které se spojují s péčí, podporou a zdroji, aby vedly zdravější život. Slouží přibližně 118 milionům lidí prostřednictvím portfolia lékařských, digitálních, lékárenských, behaviorálních, klinických a pečovatelských řešení. Společnost byla dříve známá jako Anthem, Inc. a v červnu 2022 změnila svůj název na Elevance Health Inc. Elevance Health Inc. byla založena v roce 1944 a sídlí v Indianapolis v Indianě.

Sektor

Healthcare

Odvětví

Medical - Healthcare Plans

Počet zaměstnanců

104200

Založení

2001-10-30

Adresa

220 Virginia Avenue

CEO

Gail Koziara Boudreaux

Web

www.elevancehealth.com

Podobné společnosti

Cigna Corporation

$ 260.66

- $ 3.93

REGN

Regeneron Pharmaceuticals, Inc.

$ 660.00

+ $ 2.47

ZTS

Zoetis Inc.

$ 119.67

- $ 0.57

HUM

Humana Inc.

$ 243.67

- $ 8.38

IDXX

IDEXX Laboratories, Inc.

$ 700.73

- $ 7.72

CVS

CVS Health Corporation

$ 77.62

- $ 1.37

GSK

GSK plc

$ 46.75

+ $ 0.12

Zahraniční články

Výsledovka

Rozvaha

Peněžní toky

Výsledovka

Rozvaha

Peněžní toky

V miliardách (USD)

Revenue	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Total Revenues	199.1	199.1	176.8	171.3	156.6	138.6	121.9	104.2	92.1	90.0	84.9	79.2	73.9	71.0	61.7	60.7	58.8
Cost of Revenues	148.2	148.2	0.0	17.3	13.0	10.9	9.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Gross Profit	50.9	50.9	176.8	154.0	143.6	127.7	112.9	102.2	92.1	90.0	84.9	79.2	73.9	71.0	61.7	60.7	58.8

Revenue	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Total Revenues	49.7	50.7	49.8	48.9	45.4	45.1	43.6	42.6	42.6	42.8
Cost of Revenues	38.1	38.1	36.7	35.3	0.0	0.0	0.0	0.0	31.3	30.6
Gross Profit	11.7	12.6	13.1	13.6	45.4	45.1	43.6	42.6	11.3	12.2

Operating Income	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
R&D Expenses	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Selling General & Admin Expenses	0.0	0.0	0.0	36.2	17.7	15.9	17.5	13.4	14.0	12.6	12.6	12.5	11.7	10.0	8.7	8.4	8.8
Depreciation & Amortization	1.5	1.5	1.4	1.7	1.7	1.3	1.2	1.1	1.1	0.9	0.9	0.9	0.9	0.9	0.7	0.6	0.1
Total Operating Expenses	42.8	42.8	168.9	36.2	17.7	15.9	-126.0	-98.2	-86.3	12.6	12.6	12.5	11.7	10.0	8.7	8.4	8.8
Operating Income	8.1	8.1	7.9	134.0	7.8	7.9	6.2	6.0	5.1	4.0	4.6	4.6	4.4	3.8	3.9	4.0	4.4

Operating Income	TTM	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
R&D Expenses	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Selling General & Admin Expenses	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Depreciation & Amortization	0.4	0.4	0.4	0.4	0.4	0.3	0.3	0.3	0.4	0.4
Total Operating Expenses	11.1	10.8	10.4	10.4	44.8	43.8	40.7	39.6	10.1	10.3
Operating Income	0.6	1.8	2.6	3.1	0.6	1.4	3.0	2.9	1.3	1.9

Net Income	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Interest Income	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Interest Expense	1.4	1.4	1.2	1.0	0.9	0.8	0.8	0.7	0.8	0.7	0.7	0.7	0.6	0.6	0.5	0.4	0.4
Other Expense	-1.4	-1.4	0.0	-126.2	-0.9	12.6	10.4	-82.9	-0.8	0.0	0.0	0.0	0.0	0.0	0.3	3.9	3.8
IBT	6.7	6.7	7.9	7.7	7.8	7.9	6.2	6.0	5.1	4.0	4.6	4.6	4.4	3.8	3.9	4.0	4.4
Income Tax Expense	1.0	1.0	1.9	1.7	1.8	1.8	1.7	1.2	1.3	0.1	2.1	2.1	1.8	1.2	1.2	1.3	1.5
Net Income	5.7	5.7	6.0	6.0	6.0	6.1	4.6	4.8	3.8	3.8	2.5	2.6	2.6	2.5	2.7	2.6	2.9

Net Income	TTM	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Interest Income	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Interest Expense	0.4	0.4	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3
Other Expense	-0.4	-0.4	-0.3	-0.3	0.0	0.0	0.0	0.0	-33.0	-31.1
IBT	0.2	1.4	2.3	2.8	0.6	1.4	3.0	2.9	1.0	1.7
Income Tax Expense	-0.3	0.2	0.5	0.6	0.2	0.4	0.7	0.7	0.2	0.4
Net Income	0.5	1.2	1.7	2.2	0.4	1.0	2.3	2.2	0.9	1.3

Per Share Data	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
EPS	$0.00	$0.00	$0.00	$25.69	$25.10	$25.04	$18.23	$18.81	$14.95	$15.01	$9.36	$9.80	$9.58	$8.49	$8.71	$7.80	$7.64
EPS Diluted	$0.00	$0.00	$0.00	$25.22	$24.81	$24.73	$17.98	$18.47	$14.75	$14.35	$9.21	$9.38	$8.99	$8.20	$8.18	$7.25	$6.94
Shares Outstanding	0.2	0.2	0.2	0.2	0.2	0.2	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.4
Diluted Shares Outstanding	0.2	0.2	0.2	0.2	0.2	0.2	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.4	0.4

Per Share Data	TTM	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
EPS	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$3.67	$5.48
EPS Diluted	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$3.63	$5.45
Shares Outstanding	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2
Diluted Shares Outstanding	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2

Current Assets	TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Cash And Equivalents	6.5	8.3	6.5	7.4	4.9	5.7	4.9	3.9	3.6	4.1	2.1	2.2	1.6	2.5	2.2	1.8
Short Term Investments	29.5	25.2	29.6	26.0	26.3	23.4	19.7	16.7	17.4	17.2	16.9	17.5	17.1	16.9	17.1	17.3
Total Cash & ST Investments	35.4	33.5	6.5	7.4	31.1	29.2	24.6	20.6	21.0	21.3	19.1	19.6	18.6	19.4	2.2	1.8
Accounts Receivable	19.2	19.1	10.0	16.0	13.4	11.0	10.6	9.3	8.8	8.6	7.3	7.3	5.3	4.8	4.5	4.0
Inventory	-17.7	0.0	0.0	-11.4	-38.5	-34.3	-29.1	-25.6	-17.7	-17.3	-17.3	-17.8	-17.3	-17.2	-0.1	0.0
Other Current Assets	62.3	0.0	43.5	43.6	38.5	34.3	29.1	25.6	24.2	21.8	21.7	23.1	23.1	21.2	20.5	20.4
Total Current Assets	62.3	52.6	60.0	55.6	44.6	40.1	35.2	30.0	36.3	34.3	30.9	32.2	29.7	28.3	27.1	26.1

Current Assets	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Cash And Equivalents	8.7	8.6	7.5	8.3	7.9	6.5	6.2	6.5	10.9	10.0
Short Term Investments	0.0	25.3	25.4	25.2	29.0	28.9	29.5	29.6	27.8	28.0
Total Cash & ST Investments	8.7	33.9	32.9	33.5	36.8	35.4	35.8	36.1	38.7	10.0
Accounts Receivable	0.0	23.1	22.2	19.1	18.4	19.2	18.3	10.0	9.0	9.1
Inventory	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-54.0	-35.7	-7.4
Other Current Assets	55.1	-57.0	-55.1	0.0	-55.2	-54.6	-54.0	43.5	41.2	40.7
Total Current Assets	63.8	0.0	0.0	52.6	0.0	0.0	0.0	60.0	61.2	59.7

Long-Term Assets	TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Net Property, Plant & Equipment	4.5	5.2	4.4	4.3	3.9	3.5	3.1	2.7	2.2	2.0	2.0	1.9	1.8	1.7	1.4	1.2
Goodwill	26.0	28.3	25.3	24.4	24.2	21.7	20.5	20.5	19.2	17.6	17.6	17.1	16.9	17.5	13.9	13.3
Intangible Assets	10.4	12.1	10.3	10.3	10.6	9.4	8.7	9.0	8.4	8.0	8.2	8.0	8.4	9.1	7.9	8.0
Long-Term Investments	30.3	0.0	6.1	27.7	28.8	25.6	21.2	18.7	21.6	19.2	19.0	19.9	19.3	18.6	17.4	17.3
Other Long-Term Assets	15.1	18.7	2.8	-19.8	-67.5	-60.1	-53.5	-51.0	4.5	3.2	3.1	-17.4	-17.0	-16.5	-16.1	-16.2
Total Long-Term Assets	50.7	64.3	48.9	47.2	67.5	60.1	53.5	51.0	34.3	30.8	30.9	29.8	29.8	30.7	24.9	24.0
Total Assets	113.0	116.9	108.9	102.8	97.3	86.6	77.5	71.6	70.5	65.1	61.7	62.1	59.6	59.0	52.0	50.2

Long-Term Assets	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Net Property, Plant & Equipment	4.7	4.6	4.6	5.2	4.5	4.5	4.5	4.4	4.2	4.5
Goodwill	28.5	28.4	28.4	28.3	26.0	26.0	25.9	25.3	25.3	25.3
Intangible Assets	11.3	11.5	11.9	12.1	10.3	10.4	10.7	10.3	10.5	10.7
Long-Term Investments	11.8	27.3	27.2	0.0	31.0	30.3	30.9	30.7	28.8	29.1
Other Long-Term Assets	2.8	-71.8	-72.2	18.7	-71.8	-71.2	-72.0	9.0	9.3	8.9
Total Long-Term Assets	59.0	0.0	0.0	64.3	0.0	0.0	0.0	48.9	49.3	49.4
Total Assets	122.7	121.9	119.7	116.9	116.5	113.0	111.9	108.9	110.5	109.2

Current Liabilities	TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Accounts Payable	5.8	22.7	23.0	20.6	18.5	16.9	13.0	12.4	13.0	11.9	10.9	10.5	9.6	9.3	3.1	2.9
Short-Term Debt	3.1	2.0	1.9	1.8	1.9	0.7	2.3	2.0	2.5	1.4	0.5	1.0	0.9	0.8	1.4	0.8
Other Current Liabilities	31.4	0.0	15.5	16.2	-21.5	-18.8	-16.4	-15.3	6.9	7.0	6.5	6.1	5.1	4.8	10.4	9.4
Current Liabilities	41.8	26.2	41.8	39.7	21.5	18.8	16.4	15.3	23.4	21.3	19.1	18.8	16.4	15.8	15.8	14.0

Current Liabilities	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Accounts Payable	0.0	24.4	23.9	22.7	21.6	21.0	22.1	23.0	22.2	21.2
Short-Term Debt	0.9	2.0	1.9	2.0	2.5	3.1	4.5	1.9	0.8	0.3
Other Current Liabilities	39.9	-28.0	-27.5	0.0	-25.9	-25.6	-28.1	15.5	16.0	15.7
Current Liabilities	40.9	0.0	0.0	26.2	0.0	0.0	0.0	41.8	43.3	41.6

Long-Term Liabilities	TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Long-Term Debt	24.6	29.2	23.2	22.3	21.2	19.3	17.8	17.2	17.4	14.4	15.3	14.1	13.6	14.2	8.4	8.1
Capital Leases	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Def. Tax Liability	2.0	2.1	2.0	2.0	2.7	2.0	2.2	2.0	1.7	2.8	2.6	3.2	3.3	3.4	2.7	2.6
Total Liabilities	70.7	75.5	69.5	66.4	61.2	53.4	45.7	43.0	44.0	40.0	38.7	37.8	34.8	35.2	28.7	26.4

Long-Term Liabilities	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Long-Term Debt	0.0	28.2	28.1	29.2	24.7	24.6	22.0	23.2	24.0	24.9
Capital Leases	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.7	0.7
Def. Tax Liability	2.3	2.0	2.1	2.1	2.1	2.0	2.2	2.0	1.8	1.9
Total Liabilities	78.7	78.1	77.1	75.5	72.7	70.7	71.2	69.5	71.9	70.9

Total Common Equity	TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Common Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Retained Earnings	34.6	33.5	31.7	29.7	27.1	23.8	22.6	20.0	18.1	16.6	14.8	14.0	13.8	12.6	11.5	10.7
Comprehensive Income	-1.4	-1.1	-1.3	-2.5	-0.2	0.2	-0.3	-1.0	-0.1	-0.3	-0.3	0.2	0.2	0.3	0.1	0.2
Total Common Equity	42.2	41.3	39.3	36.3	36.1	33.2	31.7	28.5	26.5	25.1	23.0	24.3	24.8	23.8	23.3	23.8

Total Common Equity	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Common Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Retained Earnings	35.6	35.5	34.5	33.5	35.2	34.6	33.1	31.7	32.1	31.6
Comprehensive Income	-0.5	-0.8	-0.9	-1.1	-0.5	-1.4	-1.4	-1.3	-2.5	-2.2
Total Common Equity	44.0	43.7	42.5	41.3	43.8	42.2	40.6	39.3	38.4	38.2

Other		TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Total Debt		27.7	31.2	25.1	24.1	23.0	20.0	20.1	19.2	19.9	15.7	15.9	15.2	14.5	15.0	9.8	9.0
Book Value		42.3	41.4	39.4	36.4	36.1	33.2	31.7	28.5	26.5	25.1	23.0	24.3	24.8	23.8	23.3	23.8

Other		3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Total Debt		0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
Book Value		44.0	43.7	42.5	41.3	43.8	42.2	40.6	39.3	38.4	38.2

Cash Flow From Operating Activities	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Net Income	6.7	5.7	6.0	6.0	6.0	6.1	4.6	4.8	3.8	3.8	2.5	2.6	2.6	2.7	2.7	2.6	2.9
Depreciation & Amortization	1.5	1.5	1.4	1.7	1.7	1.3	1.2	1.1	1.1	0.9	0.9	0.9	0.9	0.9	0.7	0.6	0.1
Stock-Based Compensation	0.3	0.3	0.2	0.3	0.3	0.3	0.3	0.3	0.2	0.2	0.2	0.1	0.2	0.1	0.1	0.1	0.1
Change Working Capital	-7.1	-3.3	-1.7	-0.5	0.3	0.8	5.2	-0.2	-1.6	0.4	-0.6	0.7	-0.2	-0.8	-0.7	0.1	-2.2
Change In Accounts Receivable	-1.0	-2.5	0.0	0.0	0.0	0.0	0.0	-1.1	-0.7	0.0	-1.4	0.0	-1.9	-0.4	0.2	0.0	0.0
Change In Accounts Payable	1.8	-0.7	-0.3	1.6	0.3	0.7	2.0	-0.6	0.1	0.9	0.1	-0.2	0.0	0.3	-0.4	0.0	-0.1
Change In Inventories	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	-1.1	-0.1	0.8	0.9	1.6	-0.5	-0.1	0.0	0.0
Other Non-cash Items	1.5	0.4	0.0	1.2	0.3	-0.2	0.0	-0.1	0.2	0.2	0.1	-0.2	-0.1	0.0	-0.3	-0.2	0.4
Cash from Operations	2.1	0.0	0.0	8.1	8.4	8.4	10.7	6.1	3.8	4.2	3.2	4.1	3.4	3.1	2.7	3.4	1.4

Cash Flow From Operating Activities	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Net Income	0.5	1.2	1.7	2.2	0.4	1.0	2.3	2.2	0.8	1.3
Depreciation & Amortization	0.4	0.4	0.4	0.4	0.4	0.3	0.3	0.3	0.4	0.4
Stock-Based Compensation	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1
Change Working Capital	-0.5	-0.8	-0.2	-1.8	1.5	1.2	-2.0	-1.0	-4.4	0.2
Change In Accounts Receivable	0.8	0.8	-0.9	-3.2	0.5	0.9	-1.1	-0.3	0.7	-0.4
Change In Accounts Payable	-2.3	-0.2	0.7	1.0	-1.2	0.6	0.6	-0.3	-0.1	1.6
Change In Inventories	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	-0.7	0.4
Other Non-cash Items	-0.1	0.0	0.1	0.3	-1.5	0.3	-0.2	0.2	0.3	0.6
Cash from Operations	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-3.0	2.6

Cash Flow From Investing Activities	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Capital Expenditure	-1.2	-1.1	-1.3	-1.3	-1.2	-1.1	-1.0	-1.1	-1.2	-0.8	-0.6	-0.6	-0.6	-0.6	-0.5	-0.5	-0.5
Acquisitions	-0.6	0.1	-4.4	-1.6	-0.6	-3.5	-2.0	0.0	-1.8	-2.1	0.0	-0.6	0.7	0.0	-4.6	-0.6	0.0
Investments	-8.6	-15.0	-18.0	-16.2	-24.9	-18.7	-19.5	-23.0	-9.7	-16.4	-12.1	-11.9	-10.8	-14.9	-15.6	-12.5	-11.0
Sales of Investment	6.2	15.1	18.6	13.5	22.6	14.6	16.1	21.0	11.6	13.5	12.0	11.8	10.3	13.7	15.9	12.7	10.8
Other Investing Activities	-0.5	0.0	0.0	0.0	-0.4	-1.0	-0.9	0.2	-0.2	0.6	0.2	0.2	-0.5	-0.4	0.3	0.0	-0.6
Cash from Investing	-4.8	0.0	0.0	-5.6	-4.6	-9.6	-7.3	-2.8	-1.3	-5.1	-0.5	-1.2	-1.0	-2.2	-4.6	-0.9	-1.3

Cash Flow From Investing Activities	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Capital Expenditure	-0.3	-0.4	-0.3	-0.2	-0.3	-0.3	-0.3	-0.3	-0.3	-0.3
Acquisitions	0.0	0.0	0.1	0.0	-3.7	0.0	0.4	-1.1	0.0	0.1
Investments	-2.8	-4.2	-4.1	-4.0	-3.3	-4.7	-3.9	-6.1	8.1	-6.7
Sales of Investment	3.2	3.4	3.9	4.6	5.5	4.5	3.2	5.4	-8.8	6.4
Other Investing Activities	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-0.1
Cash from Investing	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-1.0	-0.7

Cash Flow From Financing Activities	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Debt Repaid	-2.4	0.0	0.0	0.7	-3.6	-2.1	-0.9	-0.9	-1.3	-7.8	-0.1	-1.7	-0.4	-2.0	-1.5	-0.7	-0.7
Debt Issued	5.0	31.2	6.1	1.7	4.7	5.1	0.8	1.8	0.6	12.0	-0.1	2.4	1.0	1.5	6.7	1.5	9.6
Issuance of Common Stock	0.2	0.0	0.0	0.2	0.2	6.0	1.6	1.3	1.3	0.2	0.1	0.2	0.3	0.5	0.1	2.1	0.0
Repurchase of Common Stock	-2.4	-2.6	-2.9	-2.7	-2.3	-1.9	-2.7	-1.7	-1.7	-2.0	0.2	-1.5	-3.0	-1.6	-2.5	-3.0	-4.4
Dividends Paid	-1.5	0.0	0.0	-1.4	-1.2	-1.1	-1.0	-0.8	-0.8	-0.7	-0.7	-0.7	-0.5	-0.4	-0.4	-0.4	0.0
Other Financing Activities	0.9	0.0	0.0	0.2	5.6	-0.5	0.4	-0.1	0.3	10.7	-0.3	0.7	1.7	1.8	6.3	0.0	1.9
Cash from Financing	-0.7	0.0	0.0	-3.3	-1.3	0.4	-2.6	-2.3	-2.2	0.4	-0.7	-3.0	-1.8	-1.7	2.1	-2.0	-3.2

Cash Flow From Financing Activities	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Debt Repaid	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-0.3
Debt Issued	0.9	-29.3	0.2	-1.2	4.1	-0.5	1.2	1.3	0.3	0.0
Issuance of Common Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Repurchase of Common Stock	-0.5	-0.9	-0.4	-0.9	-1.8	-0.1	-0.5	-0.6	-0.9	-0.5
Dividends Paid	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-0.3	-0.3
Other Financing Activities	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1
Cash from Financing	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-0.4	-1.0

Cash position		TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Net Change in Cash		-3.5	1.2	1.8	-0.9	2.5	-0.9	0.8	1.0	0.3	-0.5	2.0	0.0	0.6	-0.9	0.3	0.4	-3.0
Closing Cash Balance		6.5	9.5	8.3	6.5	7.4	4.9	5.7	4.9	3.9	3.6	4.1	2.1	2.2	1.6	2.5	2.2	1.8

Cash position		4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Net Change in Cash		0.8	0.2	1.1	-0.8	0.4	1.4	0.3	-0.3	-4.4	0.9
Closing Cash Balance		9.5	8.7	8.6	7.5	8.3	7.9	6.5	6.2	6.5	10.9

Free Cash Flow		TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Free Cash Flow		0.8	3.2	4.6	6.8	7.2	7.3	9.7	5.0	2.6	3.4	2.6	3.5	2.7	2.4	2.2	2.9	1.0
Real Free Cash Flow		0.5	2.9	4.4	6.5	7.0	7.0	9.4	4.7	2.4	3.2	2.5	3.4	2.6	2.3	2.1	2.7	0.8

Free Cash Flow		4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Free Cash Flow		-0.2	0.8	1.8	0.8	0.4	2.3	0.1	1.7	-3.3	2.3
Real Free Cash Flow		-0.2	0.7	1.7	0.7	0.4	2.3	0.0	1.6	-3.4	2.2

Nacenění

Finance

Efektivita

Marže

Dividenda

Ostatní

Nacenění

Ukazatel	Aktuální	Historické	Konkurence
P/E	11.4	17.2	51.6
P/S	0.3	0.7	0.9
P/B	1.5	2.4	21.2
P/FCF	22.3	31.4	152.6
Market cap	$67.8	$83.6

P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.

Finance

Ukazatel	Aktuální	Historické	Srovnání
Debt to Assets	0 %	22.9 %	0 %
Debt to Income	16.4 %	479.9 %	0 %
Debt to Free cash flow	32.1 %	26.1 %	0 %
Interest expense percentage	17.3 %	13 %	0 %
Current ratio	1.6	1.6	0